...State Food and Drug Administration (SFDA) approved China Medical's Topoisomerase 2-alpha (TOP2A) FISH detection kit. China Medical Technologies Inc....
China Medical Technologies Inc. (NASDAQ:CMED), Beijing, China Business: Diagnostic Date completed: 12/1/10 Type: Private placement of senior convertible notes Raised: $125 million Note: The unsecured notes bear 6.25% interest, mature on Dec. 15, 2016, and...
...China's State Food and Drug Administration (SFDA) approved China Medical Technologies' EGFR PCR Assay to provide a qualitative... ...common somatic mutations in the EGFR gene of patients with non-small cell lung cancer (NSCLC). China Medical Technologies Inc....
...China's State Food and Drug Administration (SFDA) granted marketing approval to China Medical Technologies for its Breast Cancer... ...FISH probe to detect amplification of the HER-2 gene in human breast cancer tissue samples. China Medical Technologies Inc....
...State Food and Drug Administration (SFDA) approved China Medical's Topoisomerase 2-alpha (TOP2A) FISH detection kit. China Medical Technologies Inc....
China Medical Technologies Inc. (NASDAQ:CMED), Beijing, China Business: Diagnostic Date completed: 12/1/10 Type: Private placement of senior convertible notes Raised: $125 million Note: The unsecured notes bear 6.25% interest, mature on Dec. 15, 2016, and...
...China's State Food and Drug Administration (SFDA) approved China Medical Technologies' EGFR PCR Assay to provide a qualitative... ...common somatic mutations in the EGFR gene of patients with non-small cell lung cancer (NSCLC). China Medical Technologies Inc....
...China's State Food and Drug Administration (SFDA) granted marketing approval to China Medical Technologies for its Breast Cancer... ...FISH probe to detect amplification of the HER-2 gene in human breast cancer tissue samples. China Medical Technologies Inc....